Table 2 Clinical and demographic characteristics of the 130 obese patients
Patients (n = 130) | Women (n = 103) | Men (n = 27) | |
|---|---|---|---|
Age (years) | 42 (± 11) | 42 (± 11) | 42 (± 11) |
Height (cm) | 167 (± 8) | 164 (± 6) | 178 (± 6) |
Weight (kg) | 124.6 (± 22.2) | 119.2 (± 19.5) | 145.2 (± 20.2) |
BMI (kg/m2) | 44.8 (± 6.8) | 44.4 (± 6.6) | 46.0 (± 7.2) |
Comorbidities | |||
Hypertension | 44 (34%) | 30 (29%) | 14 (52%) |
Diabetes | 24 (18%) | 16 (16%) | 8 (30%) |
Dyslipidemia | 19 (15%) | 11 (11%) | 8 (30%) |
Severe OSAS | 36 (28%) | 21 (21%) | 15 (56%) |
Treatments | |||
Antihypertensive drugs | 38 (29%) | 27 (26%) | 11 (42%) |
Oral antidiabetics | 22 (17%) | 15 (15%) | 7 (26%) |
Insulin | 11 (8%) | 7 (7%) | 4 (15%) |
Cholesterol-lowering agents | 8 (6%) | 5 (5%) | 3 (12%) |
Smoking history (n = 103) | |||
Current | 13 (28%) | 8 (28%) | 5 (29%) |
Former | 33 (32%) | 21 (27%) | 12 (50%) |
Never | 56 (54%) | 49 (62%) | 7 (30%) |
Pack-years | 16 (± 15) | 11 (± 10) | 25 (± 20) |